Log in to search using one of your social media accounts:

 

Correspondence HPV control and resistance in the Middle East and north Africa

We thank Murat G ültekin and Baki Akgül,1 and we agree wholeheartedly with the fact that Islamic countries, and countries with more conservative sexual views based on religion in general, should implement educational projects in government-organised programmes. As we mentioned in our original Correspondence,2 the organisation of intervention policies based on awareness campaigns can be a very effective first step in the control of cervical cancer caused by HPV. However, a point that we would like to stress once more is that acceptance and implementation of these programmes, and in effect also vaccines, can b e faced with difficulties because of stigmatisation that is based on religious and traditional values.
Source: The Lancet Infectious Diseases - Category: Infectious Diseases Authors: Tags: Correspondence Source Type: research

Related Links:

ConclusionFor both RA and non‐RA patients, compliance with Canadian recommendations for preventive medical services and screening for comorbid conditions in primary care was less than optimal. This indicates key targets for improvement.
Source: Arthritis Care and Research - Category: Rheumatology Authors: Tags: Original Article Source Type: research
AbstractHispanic populations have low HPV vaccination rates, although the vaccine is safe and efficacious. We surveyed a low-income Hispanic population to characterize knowledge gaps about the HPV vaccine and understand factors associated with the decision to vaccinate a child to determine how physicians can enhance vaccination rates. Surveys in English and Spanish were distributed to parents of children under age 18. Statistical analysis included logistic regression. Knowledge that the vaccine can prevent invasive cervical cancer most impacted intent to vaccinate. Physician recommendation to vaccinate was far more influen...
Source: Journal of Immigrant and Minority Health - Category: International Medicine & Public Health Source Type: research
This study explores the general knowledge of Human Papillomavirus vaccine (HPV) and cervical cancer screening (CCS) among Somali men in the U.S., who are major decision-makers in Somali households. HPV infects both men and women, and causes genital warts and cervical cancer (CC). High mortality from CC persists among minorities due to low uptake of preventive tools. Eleven questions assessed general knowledge of HPV and CCS among 30 Somali male respondents. The knowledge of HPV and CCS by education level, age, and years lived in the U.S., was assessed using the health belief model. Most respondents had no knowledge of HPV ...
Source: Journal of Immigrant and Minority Health - Category: International Medicine & Public Health Source Type: research
Cochrane Reviews are systematic reviews of research in health care and policy. They are internationally recognized as a high-quality source of evidence for decision-making. They collate and summarize all the best available research evidence on the effects of healthcare interventions or the accuracy of diagnostic tests into a systematic review.Diagnostic Test Accuracy Reviews (DTA) provide essential information regarding the accuracy of the available diagnostic tools for key decision makers, including patients, clinicians, guideline developers and researchers.  The purpose of a Cochrane DTA review is very like the purp...
Source: Cochrane News and Events - Category: Information Technology Authors: Source Type: news
This article is protected by copyright. All rights reserved.
Source: International Journal of Cancer - Category: Cancer & Oncology Authors: Tags: Research Article Source Type: research
Publication date: October 2017 Source:Preventive Medicine, Volume 103 Author(s): Meg Watson, Ashwini Soman, Elaine W. Flagg, Elizabeth Unger, Dennis Deapen, Vivien W. Chen, Lauren C. Peres, Glenn Copeland, Thomas C. Tucker, Erin Garnett, Mona Saraiya Surveillance of cervical intraepithelial neoplasia grade III (CIN III) and adenocarcinoma in situ (AIS) is important for determining the burden of a preventable disease, identifying effects of vaccination on future diagnoses, and developing targeted programs. We analyzed population-based rates of high-grade cervical cancer precursor lesions using data from four central cancer...
Source: Preventive Medicine - Category: International Medicine & Public Health Source Type: research
Conclusions There are still barriers to cervical cancer screening among women in Uganda, where there is a need for culture-specific, sensitive information and interventions to address the issues of improving the cervical cancer screening uptake among these women. Societal context needs to be taken into account when implementing community-based health education. PMID: 28795916 [PubMed - in process]
Source: Global Health Action - Category: International Medicine & Public Health Tags: Glob Health Action Source Type: research
The vast majority (86% or 453,000 cases) of the global burden of cervical cancer occurs in Africa, Latin America and the Caribbean and Asia, where one in nine new cancer cases are of the cervix. Although the disease has become rare in high‐resource settings (e.g., in North America, parts of Europe, Japan) that have historically invested in effective screening programs, the patterns and trends are variable elsewhere. While favourable incidence trends have been recorded in many populations in Asia and Latin America and the Caribbean in the past decades, rising rates have been observed in sub‐Saharan African countries, wh...
Source: International Journal of Cancer - Category: Cancer & Oncology Authors: Tags: Cancer Epidemiology Source Type: research
In conclusion, this study shows that the current HPV vaccines could have great impact to reduce the burden of cervical cancer in Iran. This article is protected by copyright. All rights reserved
Source: Journal of Medical Virology - Category: Virology Authors: Tags: Research Article Source Type: research
Abstract Prophylactic human papillomavirus (HPV) vaccine represents a revolutionary step forward in preventing HPV-related cancers, especially cervical carcinoma. Alongside appropriate screening, it has the potential to dramatically reduce cervical cancer incidence and even eradicate it. Following extensive evaluations in clinical trials, the first decade of routine HPV vaccine use provides overwhelming evidence of the vaccines' safety and their real-life effectiveness. In 2016, further clinical trials showed high vaccine efficacy in adult women, especially those that were HPV DNA-negative at baseline, and indicat...
Source: Vaccine - Category: Allergy & Immunology Authors: Tags: Vaccine Source Type: research
More News: African Health | Cancer | Cancer & Oncology | Cancer Vaccines | Cervical Cancer | Education | Government | Infectious Diseases | Men | Middle East Health | Vaccines